Search

everythinglearnresearchcommunity

for

Search:↓

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.

Using finasteride with TIP extends time off period for prostate cancer patients.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Dutasteride injections can help treat hair loss in men and women.

Etanercept is safe and may help improve hidradenitis suppurativa, but more research is needed.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Dutasteride showed some prevention of prostate issues but also had limitations, especially with high-grade tumors.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Dutasteride is more effective than finasteride for hair growth with similar side effects.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Dutasteride is becoming a popular hair loss treatment, proving more effective than finasteride with similar side effects.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.